November 8: The Week in Cancer News
Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.
Progress Against Cancer
Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.
The cell-based immunotherapy was approved for adults with relapsed or refractory acute lymphoblastic leukemia. The U.S. Food and Drug Administration (FDA) has approved obecabtagene autoleucel (Aucatzyl) for the treatment of adults with relapsed or...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
A recent study on the prevalence of cancer across different vertebrate species may provide insights into cancer mechanisms in humans.
At the AACR Conference on the Science of Cancer Health Disparities, researchers shared results from interventions designed to help close cancer care gaps.
Long-term monitoring can catch side effects in childhood cancer survivors, and breast cancer screening rates remain low among transgender people.
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of blood test for colorectal cancer detection, and more.
The therapeutic was approved for certain patients with Philadelphia chromosome-positive chronic myeloid leukemia. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to asciminib (Scemblix) for adults with newly diagnosed, Philadelphia chromosome (Ph)-positive...
Asian American and Pacific Islander women face rising rates of early-onset breast cancer, and the risk for dying of COVID-19 is twice as high in people living with cancer.
Animals with longer gestation times may have fewer cancers, but the way traits relate to cancer risk is complex. Cancer occurs in animals as well as in humans, at widely varying rates among different...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More